The Relative Safety and Efficacy of Abciximab and Eptifibatide in Patients Undergoing Primary Percutaneous Coronary Intervention: Insights From A Large Regional Registry of Contemporary Percuteneous Coronary Intervention February 5, 2008 Journal American College of Cardiology
The Ongoing Importance of Smoking as a Powerful Risk Factor for ST-Segment Elevation Myocardial Infarction in Young Patients July 8, 2013 JAMA Internal Medicine
Percutaneous Coronary Intervention Complications and Guide Catheter Size: Bigger is Not Better July 1, 2009 JACC: Cardiovascular Interventions
Retroperitoneal Hematoma After Percutaneous Coronary Intervention: Prevalence, Risk Factors, Management, Outcomes and Predictors of Mortality. A report From The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Registry August 1, 2010 JACC: Cardiovascular Interventions
Contemporary use and effectiveness of N-Acetylcysteine in preventing contrast-induced nephropathy among patients undergoing percutaneous coronary intervention January 1, 2012 JACC: Cardiovascular Interventions
Impact of Automated Contrast Injector Systems on Contrast Use and Contrast Associated Complications in Patients Undergoing Percutaneous Coronary Interventions April 1, 2013 JACC: Cardiovascular Interventions
Trends in Contrast Volume Use and Incidence of Acute Kidney Injury in Patients Undergoing Percutaneous Coronary Intervention: Insights From Blue Cross Blue Shield of Michigan Cardiovascular Collaborative (BMC2) March 12, 2018 JACC: Cardiovascular Interventions
Primary and secondary vascular access site complications associated with percutaneous coronary intervention: insights from the BMC2 Registry November 25, 2019 JACC: Cardiovascular Interventions
Institutional Variability in Patient Radiation Doses ≥5 Gy During Percutaneous Coronary Intervention April 13, 2020 JACC: Cardiovascular Interventions
Percutaneous Coronary Intervention for Chronic Total Occlusion—The Michigan Experience. May 13, 2020 JACC: Cardiovascular Interventions